Naringin ameliorates type 2 diabetes mellitus-induced steatohepatitis by inhibiting RAGE/NF-κB mediated mitochondrial apoptosis.
Animals
Antioxidants
/ therapeutic use
Apoptosis
/ drug effects
Diabetes Mellitus, Experimental
/ complications
Diabetes Mellitus, Type 2
/ complications
Fatty Liver
/ drug therapy
Flavanones
/ therapeutic use
Fluorescent Antibody Technique
Glucose Tolerance Test
Hep G2 Cells
/ drug effects
Humans
Insulin
/ blood
Liver
/ pathology
Male
Mitochondria
/ drug effects
NF-kappa B
/ metabolism
Rats
Rats, Sprague-Dawley
Reactive Oxygen Species
/ metabolism
Real-Time Polymerase Chain Reaction
Receptor for Advanced Glycation End Products
/ metabolism
Mitochondrial apoptosis
NF-κB
Naringin
RAGE
Steatohepatitis
Type 2 diabetes mellitus
Journal
Life sciences
ISSN: 1879-0631
Titre abrégé: Life Sci
Pays: Netherlands
ID NLM: 0375521
Informations de publication
Date de publication:
15 Sep 2020
15 Sep 2020
Historique:
received:
27
06
2020
revised:
10
07
2020
accepted:
15
07
2020
pubmed:
24
7
2020
medline:
18
9
2020
entrez:
24
7
2020
Statut:
ppublish
Résumé
Recent findings have instituted the role of hyperglycemia-related AGE/RAGE and NF-κB in instigating reactive oxygen species (ROS) mediated mitochondrial dysfunction and apoptosis of hepatocyte, which leads to steatohepatitis. Naringin, a flavanone glycoside found to possess myriads of pharmacological benefits along with its antioxidant and anti-inflammatory properties. Consequently, we aimed to decipher the effect of naringin on RAGE/NF-κB mediated mitochondrial apoptosis in type 2 diabetes mellitus (T2DM)-induced steatohepatitis. Hepatic HepG2 cells were cultured in palmitic acid medium with and without naringin. Lipid content was examined by Oil Red O and Nile Red staining. Cellular apoptosis was determined by Annexin V-FITC/PI staining. An experimental T2DM-induced steatohepatitis was developed in Sprague Dawley rats by high-fat diet (HFD) for 12 weeks. The naringin was administrated orally at a dose of 100 mg/kg, daily for eight weeks. Glucose and insulin tolerance test was performed. Liver sections were stained by hematoxylin-eosin and picrosirius red. The mRNA and protein expression of RAGE and NF-κB were determined by qPCR, Immunofluorescence, and Immunoblotting. Mitochondrial membrane potential (MMP), cellular and mitochondrial ROS were measured by FACS. Palmitic acid encountered HepG2 cells and HFD fed rats exhibited hyperlipidemia, insulin resistance, abnormal aminotransferases, steatosis, and fibrosis. Besides, the level of AGEs, RAGE, NF-κB, and oxidative stress were exacerbated. Moreover, MMP, cellular and mitochondrial ROS were altered in diabetic rats. Nevertheless, the naringin treatment ameliorated the steatohepatitis by improving the levels of aforementioned parameters. Collectively, these findings suggested anti-steatohepatitis potential of naringin in diabetics.
Identifiants
pubmed: 32702445
pii: S0024-3205(20)30869-9
doi: 10.1016/j.lfs.2020.118118
pii:
doi:
Substances chimiques
Antioxidants
0
Flavanones
0
Insulin
0
NF-kappa B
0
Reactive Oxygen Species
0
Receptor for Advanced Glycation End Products
0
naringin
N7TD9J649B
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
118118Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest All authors declared that there is no conflict of interest.